Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksE2V.L Regulatory News (E2V)

  • There is currently no data for E2V

Trading Statement

7 Apr 2006 07:00

e2v technologies PLC07 April 2006 e2v technologies plc 2006 Year End Trading Update e2v technologies, a specialist developer and manufacturer of high-technologyelectronic components and sub-systems is providing a period end trading update. Overall we have seen a good sales performance for the year ended 31st March2006. Sensor product sales will show modest growth, as anticipated, butElectronic Tube product sales will be better than expected, due to the earlycompletion of a specific £6.1m contract to supply electronic subsystems to theUK Ministry of Defence. Accordingly, the full year outcome is expected to be at the upper end orslightly above expectations. The company has continued to focus on operational cost improvements resulting insome additional severance costs in the second half of the year. Strong cash flows have enabled us to significantly reduce net debt at the yearend, even after the acquisition of Gresham Scientific Instruments Limited for£5.1m of cash in the first half. Keith Attwood, CEO said: "In our first full financial year since flotation wehave continued to make good progress organically and have also completed ourfirst acquisition. Our strong order book and continued focus on operationalimprovements lead us to believe the outlook is for continued progress, despitethe impact of increasing input costs of energy and materials. We continue totarget complementary "bolt on" acquisition opportunities, as well as some moresignificant opportunities, in both Europe and North America." Enquiries: e2v technologies plc Tel: 01245 453437Keith Attwood, Chief ExecutiveMike Hannant, Finance Directorwww.e2v.com Gavin Anderson & Company Tel: 0207 554 1400Fergus Wylie/Keith Brookbank NOTES FOR EDITORS: e2v technologies plc e2v technologies delivers the radio frequency and sensing technology thatenables some of the world's most innovative medical and science, aerospace anddefence, and industrial and commercial systems. For the year ended 31 March2005, e2v achieved sales of £100.5m. It is listed on the London Stock Exchange(e2v.l). e2v is a leading developer and manufacturer of high-technology electroniccomponents and subsystems, which it supplies into three core areas: •Medical & Science : Sensor technology includes Dental X-ray, Mammography, life science applications and X-ray microscopy. Electronic Tubes are the enabling technology behind radiotherapy cancer treatments and high-energy physics. •Aerospace & Defence : Sensor technology includes military surveillance, targeting and guidance; space-based imaging and astronomy and radar & electronic warfare. Electronic tubes provide the enabling technology behind radars, electronic countermeasures (ECM), electronic warfare and satellite communications. •Commercial & Industrial : Sensor technology includes marine radars, industrial safety sensors, automotive radars and alarms and thermal imaging cameras used by fire fighters. Electronic tubes provide enabling technology behind TV broadcast, satellite communications, marine radar and food & industrial processing. e2v has 1,300 employees worldwide with offices in UK, USA, Germany, France,Canada and a presence in China through the China Britain Business Council, aswell as a network of distributors covering other key territories. Further information on e2v technologies plc is available from its website,www.e2v.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Sep 20112:09 pmRNSHolding(s) in Company
12th Sep 20115:02 pmRNSTotal Voting Rights
8th Aug 20113:52 pmRNSHolding(s) in Company
4th Aug 20117:00 amRNSVermiculite Processing System Field Trial
28th Jul 20117:00 amRNSNew Banking Facilities
27th Jul 20114:28 pmRNSResult of AGM
15th Jul 201110:17 amRNSHolding(s) in Company
8th Jul 201110:47 amRNSStatement Re Boiler Room Scams
8th Jun 20113:46 pmRNSTotal Voting Rights
6th Jun 20114:49 pmRNSFinal Dividend Timetable
6th Jun 20117:00 amRNSFinal Results
27th May 20119:45 amRNSHolding(s) in Company
21st Apr 20111:55 pmRNSTotal Voting Rights
21st Apr 201112:56 pmRNSDirector/PDMR Shareholding
12th Apr 20113:00 pmRNSe2v awarded up to £6.2m development grant
11th Apr 20117:00 amRNSYear end trading update & dividend declaration
4th Mar 201110:30 amRNSHolding(s) in Company
22nd Feb 20113:45 pmRNSHolding(s) in Company
2nd Feb 20112:00 pmRNSDirector/PDMR Shareholding
31st Jan 20117:00 amRNSInterim Management Statement
28th Jan 20111:30 pmRNSDirectorate Change
20th Jan 20112:30 pmRNSBank arrangements concerning dividends
6th Dec 20104:57 pmRNSTotal Voting Rights
19th Nov 20103:21 pmRNSHolding(s) in Company
18th Nov 201012:12 pmRNSChange of Director's Details
17th Nov 20104:40 pmRNSHolding(s) in Company
15th Nov 20107:00 amRNSHalf Yearly Report
9th Nov 201012:11 pmRNSHolding(s) in Company
28th Oct 20107:00 amRNSAppointment of New Non Executive Director
12th Oct 201012:15 pmRNSHolding(s) in Company
11th Oct 20107:00 amRNSPeriod end update
7th Sep 20107:00 amRNSUpdate on Restructuring
25th Aug 201010:40 amRNSHolding(s) in Company
11th Aug 201011:15 amRNSHolding(s) in Company
4th Aug 20108:45 amRNSAwards under Long Term Incentive Plan
29th Jul 20102:57 pmRNSAGM Statement
26th Jul 20107:00 amRNSStrategy Briefing
23rd Jul 201012:42 pmRNSTotal Voting Rights
19th Jul 20107:00 amRNSInterim Management Statement
14th Jul 201010:15 amRNSHolding(s) in Company
21st Jun 20104:35 pmRNSPrice Monitoring Extension
4th Jun 201011:38 amRNSHolding(s) in Company
17th May 201012:53 pmRNSTotal Voting Rights
10th May 20107:00 amRNSAppointment of corporate broker
7th May 20102:00 pmRNSHolding(s) in Company
4th May 20101:35 pmRNSHolding(s) in Company
29th Apr 20109:19 amRNSAdditional Listing
28th Apr 20103:40 pmRNSHolding(s) in Company
12th Apr 20107:00 amRNS2010 Year End Trading update
7th Apr 20109:20 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.